Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore CatheterFirst clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division
Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution PartnershipPartnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval
Toro Neurovascular Announces First Patient Treated in Clinical Trial for SuperBore Aspiration Catheter for Acute Ischemic Stroke
Toro Neurovascular, an innovative medical device company, is excited to announce the successful treatment of the first patient using its Toro 88 SuperBore Aspiration Catheter as part of a first-in-man clinical study. The procedure, performed by esteemed neurosurgeon Nobuyuki Sakai, MD, DMSc., and his staff at Shimizu Hospital in Japan, marks a key milestone in Toro’s mission to transform stroke treatment through cutting-edge technology.
